Similar articles

• Reply to S.E. Krown et al.

  Akindele L, Bower M. Akindele L, et al. J Clin Oncol. 2014 Aug 10;32(23):2513-4. doi: 10.1200/JCO.2014.56.3833. Epub 2014 Jul 7. J Clin Oncol. 2014. PMID: 25002719 No abstract available.
• Broader implications of a stage-guided stratified therapeutic approach for AIDS-related Kaposi's sarcoma.

  Krell J, Stebbing J. Krell J, et al. J Clin Oncol. 2014 Feb 10;32(5):373-5. doi: 10.1200/JCO.2013.53.7126. Epub 2013 Dec 30. J Clin Oncol. 2014. PMID: 24378412 No abstract available.
• Stage-stratified approach to AIDS-related Kaposi's sarcoma: implications for resource-limited environments.

  Krown SE, Borok MZ, Campbell TB, Casper C, Dittmer DP, Hosseinipour MC, Mitsuyasu RT, Mosam A, Orem J, Phipps WT. Krown SE, et al. J Clin Oncol. 2014 Aug 10;32(23):2512-3. doi: 10.1200/JCO.2014.55.8999. Epub 2014 Jul 7. J Clin Oncol. 2014. PMID: 25002726 Free PMC article. No abstract available.
• New developments in the etiopathogenesis and treatment of HIV-related Kaposi's sarcoma.

  Whelan P, Scadden DT. Whelan P, et al. Clin Dermatol. 2000 Jul-Aug;18(4):469-77. doi: 10.1016/s0738-081x(99)00142-x. Clin Dermatol. 2000. PMID: 11024314 Review. No abstract available.
• Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity.

  Yarchoan R, Pluda JM, Wyvill KM, Aleman K, Rodriguez-Chavez IR, Tosato G, Catanzaro AT, Steinberg SM, Little RF. Yarchoan R, et al. Crit Rev Immunol. 2007;27(5):401-14. doi: 10.1615/critrevimmunol.v27.i5.10. Crit Rev Immunol. 2007. PMID: 18197804 Review.